BRCA1 gene expression in breast cancer: A correlative study between real-time RT-PCR and immunohistochemistry

Journal of Histochemistry and Cytochemistry

Volumn 53, Issue 5, 2005, Pages 621-629

  Al Mulla, Fahd ^a   Abdulrahman, Mahera ^a   Varadharaj, Govindarajulu ^a   Akhter, Nadeem ^a   Anim, Jehoram T ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

BRCA1; Breast cancer; Immunohistochemistry; MRNA; Protein; Real time RT PCR

Indexed keywords

ANTIBODY; BRCA1 PROTEIN; EPITOPE; MESSENGER RNA; PARAFFIN;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ANTIBODY SPECIFICITY; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER SCREENING; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; BRCA1 PROTEIN; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PARAFFIN EMBEDDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 17844406861     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1369/jhc.4A6544.2005     Document Type: Article

References (51)

1. Baldassarre G, Battista S, Belletti B, Thakur S, Pentimalli F, Trapasso F, Fedele M, et al. (2003) Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinoma. Mol Cell Biol 23:2225-2238
2. Bernard-Gallon DJ, Crespin NC, Maurizis JC, Bignon YJ (1997) Cross-reaction between antibodies raised against the last 20 C-terminal amino acids of BRCA 1 (C-20) and human EGF and EGF-R in MCF 10a human mammary epithelial cell line. Int J Cancer 71:123-126
3. Chen CF, Li S, Chen Y, Chen PL, Sharp ZD, Lee WH (1996) The nuclear localization sequences of the BRCA1 protein interact with the importin-alpha subunit of the nuclear transport signal receptor. J Biol Chem 271:32863-32868
4. Chen Y, Chen CF, Riley DJ, Allred DC, Chen PL, Von Hoff D, Osborne CK, et al. (1995) Aberrant subcellular localization of BRCA1 in breast cancer. Science 270:789-791
5. Coene E, Van Oostveldt P, Willems K, van Emmelo J, De Potter CR (1997) BRCA1 is localized in cytoplasmic tube-like invaginations in the nucleus. Nat Genet 16:122-124
6. Dalton LW, Page DL, Dupont WD (1994) Histologic grading of breast carcinoma. A reproducibility study. Cancer 73:2765-2770
7. Dobrovic A, Simpfendorfer D (1997) Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res 57:3347-3350
8. Easton DF, Ford D, Bishop DT (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 56:265-271
9. Egawa C, Miyoshi Y, Taguchi T, Tamaki Y, Noguchi S (2001) Quantitative analysis of BRCA1 and BRCA2 mRNA expression in sporadic breast carcinomas and its relationship with clinicopathological characteristics. Jpn J Cancer Res 92:624-630
10. Egawa C, Motomura K, Miyoshi Y, Takamura Y, Taguchi T, Tamaki Y, Inaji H, et al. (2003) Increased expression of BRCA1 mRNA predicts favorable response to anthracycline-containing chemotherapy in breast cancers. Breast Cancer Res Treat 78:45-50
11. Fabbro M, Rodriguez JA, Baer R, Henderson BR (2002) BARD1 induces BRCA1 intranuclear foci formation by increasing RING-dependent BRCA1 nuclear import and inhibiting BRCA1 nuclear export. J Biol Chem 277:21315-21324
12. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, et al. (1994) BRCA1 mutations in primary breast and ovarian carcinomas. Science 266:120-122.
13. Hartman AR, Ford JM (2002) BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair. Nat Genet 32:180-184
14. Hartman AR, Ford JM (2003) BRCA1 and p53: compensatory roles in DNA repair. J Mol Med 81:700-707
15. Hill AD, Doyle JM, McDermott EW, O'Higgins NJ (1997) Hereditary breast cancer. Br J Surg 84:1334-1339
16. Hsu LC, Doan TP, White RL (2001) Identification of a gammatubulin-binding domain in BRCA1. Cancer Res 61:7713-7718
17. Jacquemier J, Eisinger F, Birnbaum D, Sobol H (1995) Histoprognostic grade in BRCA1-associated breast cancer. Lancet 345:1503
18. Khoo US, Ozcelik H, Cheung AN, Chow LW, Ngan HY, Done SJ, Liang AC, et al. (1999) Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancer. Oncogene 18:4643-4646
19. Lafarge S, Sylvain V, Ferrara M, Bignon YJ (2001) Inhibition of BRCA1 leads to increased chemoresistance to microtubule-interfering agents, an effect that involves the JNK pathway. Oncogene 20:6597-6606
20. Lakhani SR, Gusterson BA, Jacquemier J, Sloane JP, Anderson TJ, van de Vijver MJ, Venter D, et al. (2000) The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. Clin Cancer Res 6:782-789
21. Lee WY, Jin YT, Chang TW, Lin PW, Su IJ (1999) Immunolocalization of BRCA1 protein in normal breast tissue and sporadic invasive ductal carcinomas: a correlation with other biological parameters. Histopathology 34:106-112
22. Lu M, Conzen SD, Cole CN, Arrick BA (1996) Characterization of functional messenger RNA splice variants of BRCA1 expressed in nonmalignant and tumor-derived breast cells. Cancer Res 56:4578-4581
23. Lynch HT, Lynch J, Conway T, Watson P, Feunteun J, Lenoir G, Narod S, et al. (1994) Hereditary breast cancer and family cancer syndromes. World J Surg 18:21-31
24. Mancini DN, Rodenhiser DI, Ainsworth PJ, O'Malley FP, Singh SM, Xing W, Archer TK (1998) CpG methylation within the 5′ regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site. Oncogene 16:1161-1169
25. Merajver SD, Pham TM, Caduff RF, Chen M, Poy EL, Cooney KA, Weber BL, et al. (1995) Somatic mutations in the BRCA1 gene in sporadic ovarian tumours. Nat Genet 9:439-443
26. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71
27. Miyamoto K, Fukutomi T, Asada K, Wakazono K, Tsuda H, Asahara T, Sugimura T, et al. (2002) Promoter hypermethylation and post-transcriptional mechanisms for reduced BRCA1 immunoreactivity in sporadic human breast cancers. Jpn J Clin Oncol 32:79-84
28. Niwa Y, Oyama T, Nakajima T (2000) BRCA1 expression status in relation to DNA methylation of the BRCA1 promoter region in sporadic breast cancers. Jpn J Cancer Res 91:519-526
29. Orban TI, Olah E (2001) Expression profiles of BRCA1 splice variants in asynchronous and in G1/S synchronized tumor cell lines. Biochem Biophys Res Commun 280:32-38
30. Perez-Valles A, Martorell-Cebollada M, Nogueira-Vazquez E, Garcia-Garcia JA, Fuster-Diana E (2001) The usefulness of antibodies to the BRCA1 protein in detecting the mutated BRCA1 gene. An immunohistochemical study. J Clin Pathol 54:476-480
31. Rio PG, Maurizis JC, Peffault de Latour M, Bignon YJ, Bernard-Gallon DJ (1999) Quantification of BRCA1 protein in sporadic breast carcinoma with or without loss of heterozygosity of the BRCA1 gene. Int J Cancer 80:823-826
32. Ruffner H, Verma IM (1997) BRCA1 is a cell cycle-regulated nuclear phosphoprotein. Proc Nad Acad Sci USA 94:7138-7143
33. Russell PA, Pharoah PD, De Foy K, Ramus SJ, Symmonds I, Wilson A, Scott I, et al. (2000) Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers. Int J Cancer 87:317-321
34. Scully R, Chen J, Ochs RL, Keegan K, Hoekstra M, Feunteun J, Livingston DM (1997) Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell 90:425-435
35. Scully R, Ganesan S, Brown M, De Caprio JA, Cannistra SA, Feunteun J, Schnitt S, et al. (1996) Location of BRCA1 in human breast and ovarian cancer cells. Science 272:123-126
36. Shen SX, Weaver Z, Xu X, Li C, Weinstein M, Chen L, Guan XY, et al. (1998) A targeted disruption of the murine Brca1 gene causes gamma-irradiation hypersensitivity and genetic instability. Oncogene 17:3115-3124
37. Smith TM, Lee MK, Szabo CI, Jerome N, McEuen M, Taylor M, Hood L, et al. (1996) Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. Genome Res 6:1029-1049
38. Sobczak K, Krzyzosiak WJ (2002) Structural determinants of BRCA1 translational regulation. J Biol Chem 277:17349-17358
39. Sourvinos G, Spandidos DA (1998) Decreased BRCA1 expression levels may arrest the cell cycle through activation of p53 check-point in human sporadic breast tumors. Biochem Biophys Res Commun 245:75-80
40. Thakur S, Zhang HB, Peng Y, Le H, Carroll B, Ward T, Yao J, et al. (1997) Localization of BRCA1 and a splice variant identifies the nuclear localization signal. Mol Cell Biol 17:444-452
41. Thomas JE, Smith M, Rubinfeld B, Gutowski M, Beckmann RP, Polakis P (1996) Subcellular localization and analysis of apparent 180-kDa and 220-kDa proteins of the breast cancer susceptibility gene, BRCA1. J Biol Chem 271:28630-28635
42. Thompson ME, Jensen RA, Obermiller PS, Page DL, Holt JT (1995) Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet 9:444-450
43. Vaughn JP, Davis PL, Jarboe MD, Huper G, Evans AC, Wiseman RW, Berchuck A, et al. (1996) BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells. Cell Growth Differ 7:711-715
44. Vissac C, Peffault De Latour M, Communal Y, Bignon YJ, Bernard-Gallon DJ (2002) Expression of BRCA1 and BRCA2 in different tumor cell lines with various growth status. Clin Chim Acta 320:101-110
45. Wang H, Shao N, Ding QM, Cui J, Reddy ES, Rao VN (1997) BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases. Oncogene 15:143-157
46. Wilson CA, Payton MN, Elliott GS, Buaas FW, Cajulis EE, Grosshans D, Ramos L, et al. (1997) Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-delta11b. Oncogene 14:1-16
47. Wilson CA, Ramos L, Villasenor MR, Anders KH, Press MF, Clarke K, Karlan B, et al. (1999) Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nat Genet 21:236-240
48. Yoshikawa K, Honda K, Inamoto T, Shinohara H, Yamauchi A, Suga K, Okuyama T, et al. (1999) Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1-associated cases. Clin Cancer Res 5:1249-1261
49. Zhang HT, Zhang X, Zhao HZ, Kajino Y, Weber BL, Davis JG, Wang Q, et al. (1997) Relationship of p215BRCA1 to tyrosine kinase signaling pathways and the cell cycle in normal and transformed cells. Oncogene 14:2863-2869
50. Zhang J, Willers H, Feng Z, Ghosh JC, Kim S, Weaver DT, Chung JH, et al. (2004) Chk2 phosphorylation of BRCA1 regulates DNA double-strand break repair. Mol Cell Biol 24:708-718
51. Zhou C, Smith JL, Liu J (2003) Role of BRCA1 in cellular resistance to paclitaxel and ionizing radiation in an ovarian cancer cell line carrying a defective BRCA1. Oncogene 22:2396-2404